作者: Danuta Owczarek , Anetta Undas , Jonathan H. Foley , Michael E. Nesheim , Konrad Jabłonski
DOI: 10.1016/J.CROHNS.2011.06.005
关键词:
摘要: Abstract Background Thrombin activatable fibrinolysis inhibitor (TAFI) has been reported to be involved in the pathogenesis and progression of inflammatory bowel disease (IBD). Activated TAFI (TAFIa) attenuates by cleaving C-terminal lysine residues thus down-regulating plasminogen activation. To date, no reports on TAFIa IBD have published. Methods Plasma levels were measured using a functional assay 55 consecutive patients with ulcerative colitis (UC) 50 Crohn's (CD). Associations activity, hemostatic variables markers assessed. Results was higher CD than those UC. The activity correlated positively UC group, but not group. In patients, there positive correlations white blood cells, C-reactive protein fibrinogen an inverse correlation albumin. shown for protein, platelet count, while negative noted Conclusions This study is first show that increased compared its are associated both forms IBD. These findings fit hypothesis may marker active IBD, particular